LONDON, July 23, 2012 /PRNewswire/ --
Pharma IQ has just published the results of an industry-wide laboratory informatics report conducted among 6,000 pharmaceutical laboratory informatics specialists.
75% of Laboratory Informatics users listed technology investment and implementation as their number one priority between 2012 and 2015, however only 8.3% are using 'The Cloud'. Seth Pinsky, VP of Research & Development at Abbott Labs, argues, "[The] cloud hasn't helped things to be fundamentally different," while Peter Boogaard, Founder of Industrial Lab Automation, suggests, "a lack of SaaS or alternative license structures to support new customers may limit the utilisation of the current infrastructure."
Results from the survey indicate that the implementation of laboratory informatics systems in pharmaceuticals is mature, as almost 55% of respondents implemented their major piece in the last 7-11 years, with 30% having one in place for 11 years or more.
Pharma IQ asked users what the 3 biggest obstacles were in the day-to-day experience of laboratory informatics; the results indicated a few contenders. The top 2 challenges include data mining and a lack of knowledge around the standardisation of regulatory requirements, both with 41.7%. Integration with other non-informatics software systems and a lack of industry standards were also high on peoples' agenda, at 37.5%.
This survey report was created as a part of the pre-conference research for 11th Annual ELNs & Advanced Laboratory Solutions taking place 25 - 27 September, 2012 in Milan, Italy.
The results have helped to shape the agenda and final speaker line-up which features John Trigg, Director of phaseFour Informatics leading the session Un-blurring the Lines: The Evolving Laboratory Ecosystem and Daniel Domine, Head of Research Informatics from Merck presenting a case study: A Single ELN Across Biology: From Dream to Reality.
Other important topics expressed by survey respondents that will be discussed at the event include:
Media contact: Joanna, +44(0)20-7368-98421, email@example.com - Please contact for more information or images.
Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Joanna Checinska (firstname.lastname@example.org)
|SOURCE Pharma IQ|
Copyright©2012 PR Newswire.
All rights reserved